Home›People›Anna Eramo
AE

Anna Eramo

Chief Medical Officer at LB Pharmaceuticals.

ExecutivePublic company
Updated Oct 27, 2026·Latest SEC filing Sep 12, 2025·Suggest an edit

About Anna Eramo

Anna Eramo is a chief medical officer at LB Pharmaceuticals.

Anna Eramo reports to the SEC as an officer of 1 public company.

Anna Eramo first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Anna Eramo in the role, so the role may have started earlier or lasted longer.

LB Pharmaceuticals Inc.
Chief Medical Officer
2023 – 2025 · Public company (LBRX)

Key Colleagues at Startups

The people Anna Eramo works with at each company, as listed on that company's latest Form D.

LB Pharmaceuticals Inc. · Form D/A, Jan 10, 2024
RJ
Rajul Jain
Director
RN
Ran Nussbaum
Director
ZP
Zachary Prensky
Chief Executive Officer and director
RR
AV
Andrew Vaino
Executive officer
MP
Marc Panoff
Executive officer
RL
Rebecca Luse
Director
CY
Chen Yu
Director

Sources

  1. SECLB Pharmaceuticals Inc. Form D/A, filed Jan 10, 2024
  2. SECForms 3, 4 and 5 filed by Anna Eramo (SEC filer 2030921)